Fintech executive has deep experience in developing and operating new and innovative technologies in highly regulated industries
VANCOUVER, BC , Oct. 15, 2020 /CNW/ - Mind Cure Health Inc. (CSE: MCUR) ( "Mind Cure" or the "Corporation" ) is pleased today to announce the hiring of Geoff Belair as the company's new Chief Technology Officer . Mr. Belair brings with him to Mind Cure a wealth of technology leadership experience in the highly regulated industries of fintech and insurance. He will lead the management and operations of Mind Cure's internal technology processes, team and the integration and development of future technology platforms.
"Mr. Belair is the right person at the right moment for Mind Cure as we build up our internal business operation processes and develop our own innovative technologies for the market," said Philip Tapley , Chairman, President, and CEO. "In particular, his experience building and managing complex technology systems in highly regulated environments will be key as we work to establish Mind Cure as a leader in the mental health treatment revolution that is underway."
Mind Cure's leadership team believes that technology is going to play a key role in the future of this industry, from a research and development standpoint to the associated treatments and therapies with doctors and patients. As Mind Cure's Chief Technology Officer, Mr. Belair will lead all efforts to ensure that Mind Cure is making the most effective investments and developments related to its internal processes and external technology platform.
"I am thrilled to join Mr. Tapley and the world class team at Mind Cure," said Geoff Belair . "I have spent the majority of my career in highly regulated industries and know the importance of building trust and security into all facets of technological teams and operations. Technology can have a significant impact on how mental health is treated, and I look forward to driving Mind Cure's mission forward through effective technology utilization."
About Geoff Belair
With over 30 years of experience in the fintech industry, Mr. Belair has built innovative and industry-leading technology solutions to drive operations forward. He possesses a unique combination of software architecture and design experience with a deep understanding of technology adoption and change management.
By leading and empowering multidisciplinary teams throughout his career, he has delivered ground-breaking and innovative solutions throughout the fintech industry. As a senior architect and creator of the Integration Services Team with Fincentric Corporation, a banking solutions company, he led successful implementations at Stanford University's Bank in Palo Alto California and American Express Bank in Singapore. Most recently, he served as Vice President of Information Technology at Westland Insurance.
The Company has granted a total of 200,000 stock options to Mr. Belair pursuant to the terms of his executive employment agreement and the Company's incentive stock option plan (the "Plan"). The stock options are exercisable at a price of $0.79 and subject to the terms of the Plan.
About Mind Cure Health Inc.
Mind Cure is a mental health and wellness company with a mission to identify, develop and commercialize products that ease suffering, increase productivity, and enhance mental health. It is the therapeutic potential of nootropics, psychoactive products, and psychedelic substances to treat the profound distress of a world suffering from a mental health crisis that led to the formation of Mind Cure.
On Behalf of the Board of Directors
Philip Tapley , Chairman, President, and CEO
Phone: 1-888-593-8995
Forward-Looking Information
Certain statements in this news release may constitute "forward-looking information" within the meaning of applicable securities laws (also known as forward-looking statements). Forward- looking information involves known and unknown risks, uncertainties and other factors, and may cause actual results, performance or achievements or industry results, to be materially different from any future results, performance or achievements or industry results expressed or implied by such forward-looking information. Forward-looking information generally can be identified by the use of terms and phrases such as "anticipate", "believe", "could", "estimate", "expect", "feel", "intend", "may", "plan", "predict", "project", "subject to", "will", "would", and similar terms and phrases, including references to assumptions. Some of the specific forward-looking information in this news release includes, but is not limited to, statements with respect to: Mr. Belair leading the management and operations of Mind Cure's internal technology processes, team and the integration and development of future technology platforms; the intention to establish Mind Cure as a leader in the mental health treatment revolution; the belief that technology is going to play a key role in the future of the industry; Mr. Belair leading all efforts to ensure that Mind Cure is making the most effective investments and developments related to its internal processes and external technology platform; the significance of the impact on how mental health is treated and the effectiveness of technology utilization; and Mind Cure's mission to identify, develop and commercialize products that ease suffering, increase productivity and enhance mental health.
Forward-looking information is based on a number of key expectations and assumptions made by Mind Cure, including, without limitation: the COVID-19 pandemic impact on the Canadian economy and Mind Cure's business, and the extent and duration of such impact; no change to laws or regulations that negatively affect Mind Cure's business; there will be a demand for Mind Cure's products in the future; no unanticipated expenses or costs arise; Mr. Belair will be able to lead the management and operations of Mind Cure's internal technology processes, team and the integration and development of future technology platforms; the importance of technology in the future of the industry; that Mind Cure will make effective investments and developments related to its internal processes and external technology platform; and Mind Cure will be able to operate its business as planned. Although the forward-looking information contained in this news release is based upon what Mind Cure believes to be reasonable assumptions, it cannot assure investors that actual results will be consistent with such information.
Forward-looking information is provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking information involves significant risks and uncertainties and should not be read as a guarantee of future performance or results as actual results may differ materially from those expressed or implied in such forward-looking information. Those risks and uncertainties include, among other things, risks related to: the impacts of the COVID-19 pandemic on the Canadian economy, Mind Cure's industry and Mind Cure's business, which may negatively impact, and may continue to negatively impact, Mind Cure and may materially adversely affect Mind Cure's investments, results of operations, financial condition and Mind Cure's ability to obtain additional equity or debt financing, and satisfy its financial obligations; general economic conditions; Mr. Belair may not be able to lead the management and operations of Mind Cure's internal technology processes, team and the integration and development of future technology platforms; Mind Cure may not be established as a leader in the mental health treatment revolution; technology may not play a lead role in the future of Mind Cure's industry and may not have a significant impact on how mental health is treated; and changes in legislation or regulations. Management believes that the expectations reflected in the forward-looking information contained herein are based upon reasonable assumptions and information currently available; however, management can give no assurance that actual results will be consistent with such forward-looking information. Additional information on the risk factors that could affect Mind Cure can be found under "Risk Factors" in Mind Cure's final prospectus which is available on SEDAR at www.sedar.com.
The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. Forward-looking information reflects management's current beliefs and is based on information currently available to Mind Cure. The forward-looking information is stated as of the date of this news release and Mind Cure assumes no obligation to update or revise such information to reflect new events or circumstances, except as may be required by applicable law.
The CSE has neither approved nor disapproved the contents of this press release and the CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE Mind Cure Health Inc.